Synthesis and In Vitro Cytoprotective Evaluation of Novel Hydrazone Derivatives Against Oxidative Stress in Neuroblastoma Cells

Authors

  • Rousseau M Department of Pharmaceutical Chemistry, Sorbonne University, Paris, France Author
  • Wimmer A Department of Pharmacology, Medical University of Vienna, Vienna, Austria Author
  • Hribar T Department of Neuroscience, University of Ljubljana, Ljubljana, Slovenia Author

DOI:

https://doi.org/10.5281/zenodo.22662666

Keywords:

hydrazone derivatives, oxidative stress, neuroprotection, SH-SY5Y neuroblastoma cells, Nrf2/ARE pathway

Abstract

Background: Oxidative stress is a central mediator of neuronal injury in neurodegenerative disease, and hydrazone derivatives
combine radical-scavenging and metal-chelating chemistry that has made them recurrent candidates for neuroprotective drug
discovery, yet the structural features that translate chemical antioxidant activity into genuine cell-based cytoprotection remain
incompletely defined. Objective: To synthesize a structurally diverse series of isoniazid-derived aroylhydrazones and evaluate the
relationship between their chemical radical-scavenging capacity and their ability to protect SH-SY5Y neuroblastoma cells against
hydrogen peroxide (H2O2)-induced oxidative injury, including mechanistic contribution of the Nrf2/antioxidant response element
(ARE) pathway and mitochondrial protection. Methods: Ten aroylhydrazones bearing systematically varied aromatic aldehyde
substituents were synthesized and characterized spectroscopically, then evaluated for DPPH and ABTS radical scavenging and
ferric reducing antioxidant power, for cytoprotection against 300 μM H2O2 challenge in SH-SY5Y cells by MTT assay, for
intracellular reactive oxygen species (ROS) by DCFH-DA, for mitochondrial membrane potential by JC-1, and for Nrf2 nuclear
translocation and downstream antioxidant gene induction in lead compounds. Findings: The catechol-substituted hydrazone
showed the strongest direct radical-scavenging activity and the greatest cytoprotection, restoring viability to 88.4% of unstressed
control at 10 μM. A benzimidazole-substituted hydrazone with only moderate chemical antioxidant activity nonetheless produced
disproportionate cytoprotection, ROS suppression, mitochondrial membrane potential preservation, and Nrf2/ARE pathway
induction, indicating that cell-based cytoprotection reflects mechanisms beyond direct radical quenching. Conclusions: Hydrazone
cytoprotective efficacy in neuroblastoma cells is only partly predicted by cell-free antioxidant assays, and structural features
enabling Nrf2/ARE pathway engagement identify promising leads for further neuroprotective development.

References

Zgorzynska E, Dziedzic B, Walczewska A (2021) An Overview of the Nrf2/ARE Pathway and Its Role in Neurodegenerative Diseases. International Journal of Molecular Sciences, 22(17):9592, DOI:10.3390/ijms22179592.

Amoroso S, Gioielli A, Cataldi M, Di Renzo G, Annunziato L (1999) In the neuronal cell line SH-SY5Y, oxidative stress-induced free radical overproduction causes cell death without any participation of intracellular Ca2+ increase. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1452(2):151-160, DOI:10.1016/s0167-4889(99)00110-x.

Cavalli A, Bolognesi ML, Minarini A, Rosini M, Tumiatti V, Recanatini M, Melchiorre C (2008) Multi-target-Directed Ligands To Combat Neurodegenerative Diseases. Journal of Medicinal Chemistry, 51(3):347-372, DOI:10.1021/jm7009364.

Mateev E, Muhammed MT, Irfan A, Sharma S, Georgieva M, Zlatkov A (2024) Hydrazide-hydrazones as novel antioxidants - in vitro, molecular docking and DFT studies. Pharmacia, 71:1-8, DOI:10.3897/pharmacia.71.e133114.

Cukierman DS, Accardo E, Gomes RG, De Falco A, Miotto MC, Freitas MCR, Lanznaster M, Fernandez CO, Rey NA (2018) Aroylhydrazones constitute a promising class of 'metal-protein attenuating compounds' for the treatment of Alzheimer's disease. JBIC Journal of Biological Inorganic Chemistry, 23(8):1227-1241, DOI:10.1007/s00775-018-1606-0.

Skroban J, Kruk-Slomka M, Popiolek L (2026) Exploring Acylhydrazones' Properties Against Neurodegenerative Diseases and Other Clinical Applications: A Review. Pharmaceuticals, 19(5):679, DOI:10.3390/ph19050679.

Timmins GS, Deretic V (2006) Mechanisms of action of isoniazid. Molecular Microbiology, 62(5):1220-1227, DOI:10.1111/j.1365-2958.2006.05467.x.

Teneva Y, Simeonova R, Valcheva V, Angelova VT (2023) Recent Advances in Anti-Tuberculosis Drug Discovery Based on Hydrazide-Hydrazone and Thiadiazole Derivatives Targeting InhA. Pharmaceuticals, 16(4):484, DOI:10.3390/ph16040484.

Murugappan S, Dastari S, Jungare K, Barve NM, Shankaraiah N (2024) Hydrazide-hydrazone/hydrazone as enabling linkers in anti-cancer drug discovery: A comprehensive review. Journal of Molecular Structure, 1307:138012, DOI:10.1016/j.molstruc.2024.138012.

Lipinski CA, Lombardo F, Dominy BW, Feeney PJ (2001) Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Advanced Drug Delivery Reviews, 46(1-3):3-26, DOI:10.1016/s0169-409x(00)00129-0.

Yordanov Y, Tzankova V, Stefanova D, Georgieva M, Tzankova D (2025) Exploratory Data Analysis of the In Vitro Effects of Novel Hydrazide-Hydrazone Antioxidants in the Context of In Silico Predictors. Antioxidants, 14(5):566, DOI:10.3390/antiox14050566.

Georgieva MK, Anastassova N, Stefanova D, Yancheva D (2023) Radical Scavenging Mechanisms of 1-Arylhydrazone Benzimidazole Hybrids with Neuroprotective Activity. The Journal of Physical Chemistry B, 127(20):4364-4373, DOI:10.1021/acs.jpcb.2c05784.

Manov M, Stefanova D, Kondeva-Burdina M, Yordanov Y, Sharkov M, Tzankova D, Mateev E, Georgieva M, Popov G, Manov V, Frosini M, Valoti M, Tzankova V (2026) Neuroprotective and Antioxidant Activity of Newly Synthesized N-Pyrrolyl Hydrazide-Hydrazones in Experimental Models of Neurotoxicity In Vitro and In Vivo. International Journal of Molecular Sciences, 27(1):370, DOI:10.3390/ijms27010370.

Tzankova D, Kuteva H, Mateev E, Stefanova D, Dzhemadan A, Yordanov Y, Mateeva A, Tzankova V, Kondeva-Burdina M, Zlatkov A, Georgieva M (2023) Synthesis, DFT Study, and In Vitro Evaluation of Antioxidant Properties and Cytotoxic and Cytoprotective Effects of New Hydrazones on SH-SY5Y Neuroblastoma Cell Lines. Pharmaceuticals, 16(9):1198, DOI:10.3390/ph16091198.

Tufekci KU, Bayin EC, Genc S, Genc K (2011) The Nrf2/ARE Pathway: A Promising Target to Counteract Mitochondrial Dysfunction in Parkinson's Disease. Parkinson's Disease, 2011:314082, DOI:10.4061/2011/314082.

Chico L, Schirinzi E, Balestrini L, Polzella M, Siciliano G (2026) Nrf2-Activating Natural Compounds in Neurodegenerative Diseases: Targeting Oxidative Stress and Protein Aggregation. International Journal of Molecular Sciences, 27(3):1592, DOI:10.3390/ijms27031592.

Abdo MA, Badawy SA, Fadda AA, Elmorsy MR (2025) Design, synthesis, structural characterization, and antioxidant potential of novel triazole- and oxadiazole-based hydrazide-hydrazone derivatives: spectroscopic, DFT, and molecular docking studies. BMC Chemistry, 20:19, DOI:10.1186/s13065-025-01698-6.

Blois MS (1958) Antioxidant determinations by the use of a stable free radical. Nature, 181(4617):1199-1200, DOI:10.1038/1811199a0.

Re R, Pellegrini N, Proteggente A, Pannala A, Yang M, Rice-Evans C (1999) Antioxidant activity applying an improved ABTS radical cation decolorization assay. Free Radical Biology and Medicine, 26(9-10):1231-1237, DOI:10.1016/s0891-5849(98)00315-3.

Benzie IFF, Strain JJ (1996) The ferric reducing ability of plasma (FRAP) as a measure of "antioxidant power": the FRAP assay. Analytical Biochemistry, 239(1):70-76, DOI:10.1006/abio.1996.0292.

Mosmann T (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. Journal of Immunological Methods, 65(1-2):55-63, DOI:10.1016/0022-1759(83)90303-4.

Downloads

Published

2023-12-13